This invention comprises a method of treating a subject having relapsed or refractory
cancer such as leukemia with liposomal annamycin including the steps of
- (a) evaluating the subject to determine if the subject has relapsed
or refractory cancer;
- (b) administering a high-dose amount of liposomal-annamycin for at least
3 days in a 7 day period. First line cancer therapy with particular reference to
leukemia is both contemplated and useful.
